KOL development – Thought Leader Select

The Thought Leaders Driving Thought Leader Select: A Blog Series—Brian Castle

Brian Castle joined Thought Leader Select in January of 2010, as director of global marketing and client relations. Brian has 12 years of experience leading teams in business development, sales, marketing and customer services. He spent 11 years in the financial services industry, managing business units for several top banking institutions. Upon leaving the financial …

The Thought Leaders Driving Thought Leader Select: A Blog Series—Brian Castle Read More »

Top Pharmaceutical Company Chooses Thought Leader Select for KOL Development Project

Uncategorized / By bcastle

May 12, 2010 (CHAPEL HILL, NC) Thought Leader Select, a North Carolina firm dedicated to delivering the most accurate and effective key opinion leader (KOL) profiling research for the biopharmaceutical industry, announces the commencement of a significant new research assessment for a top-10 global pharmaceutical company. The pharmaceutical company chose Thought Leader Select to identify …

Top Pharmaceutical Company Chooses Thought Leader Select for KOL Development Project Read More »

Thought Leader Select’s Meade Receives Master of Public Health Degree, Certificate in Ethics

Uncategorized / By bcastle

May 11, 2010 (CHAPEL HILL, NC) Paul Meade, founder and president of Thought Leader Select, a North Carolina firm dedicated to key opinion leader (KOL) development solutions for the biopharmaceutical industry, received a master of public health degree from the University of North Carolina at Chapel Hill on May 8, 2010. The Gillings School of …

Thought Leader Select’s Meade Receives Master of Public Health Degree, Certificate in Ethics Read More »

The Thought Leaders Driving Thought Leader Select: A Blog Series—Kristen Smithwick

Uncategorized / By bcastle

Kristen Smithwick joined Thought Leader Select as its director of research operations in 2006. Kristen leads sales, marketing and strategic planning in her current role as vice president of the company. A 1998 graduate of Duke University, Kristen spent the first seven years of her career as manager of membership services at a North Carolina …

The Thought Leaders Driving Thought Leader Select: A Blog Series—Kristen Smithwick Read More »

FDA Expands Transparency, Disclosure of KOL Involvement, Mirroring Pharma Trend

Uncategorized / By bcastle

A recent Pharmaceutical Executive article outlined new US Food and Drug Administration draft guidance that would “expand transparency and disclosure when the agency grants a conflict of interest waiver to permit an individual’s participation at an FDA advisory committee meeting.” The FDA, much like the many public and private companies that make up the biopharmaceutical …

FDA Expands Transparency, Disclosure of KOL Involvement, Mirroring Pharma Trend Read More »